Cervical cancer can be successfully prevented or mitigated through routine cervical cancer screening. However, a significant disparity in screening exists in the Muslim American women population due to societal pressures, healthcare inequities, and a lack of recognition as a disparate community. This review explores these barriers and strategies in addressing them, to ultimately aims raise awareness of the health disparities of Muslim American women.
Photodynamic therapy (PDT) is considered a relatively new, but effective treatment for cancer attributed to its minimal invasiveness and versatility for a wide variety of existing cancers. However, PDT is underapplied in clinical settings due to various limitations. Despite the restriction of PDT for cancer treatment, there is increasing research that aims to find solutions to its limitations. This review analyzes the limitations of PDT for oncological use and report current solutions to them.
Luteinizing hormone-releasing hormone (LHRH) analogs are a promising androgen deprivation treatment option for patients suffering from prostate cancer. However, there has been no survey of LHRH analog treatment efficacy that considers potential side effects and compatibility with other therapies, such as external beam radiotherapy. This review aims to discover how different types of LHRH drugs can be used to treat prostate cancer, by exploring their efficacies, cardiovascular side effects, and combinatory effects with external beam radiotherapy.
The plant molecule Abrus agglutinin (AGG) is a promising anti-tumor molecule that has been shown to increase pro-apoptotic—or pro-death—biomolecules and decrease proliferative ones in multiple different cancer cell lines. Another main benefit to AGG in potential cancer treatment is its selectiveness. In mice, AGG did not show any toxic side effects at 1mg/kg and below, and at this dose, AGG still successfully targeted cancerous cells without harming normal cells. This review confirms the potential of AGG as a chemotherapeutic agent through intracellular and extracellular methods and selective cytotoxicity.
A 2021 research study conducted by the National Institutes of Health (NIH) found that the key to killing cancerous cells is allowing a period of rest for healthy cancer-fighting cells to mobilize and thrive.
The high mortality rate of pancreatic cancer is closely linked to the lack of noticeable symptoms until the disease has advanced, making early detection and intervention exceedingly challenging. However, recent advancements in diagnostic methods, medical therapies, and other contributing factors have provided avenues for detecting pancreatic cancer in its early stages. This literature review aims to shed light on the potential interventions and advancements that can aid in the battle against pancreatic cancer.
Integrating dietary treatments with chemotherapy and immunotherapy has emerged as a viable technique to improve cancer treatment success in recent years. One such example are ketogenic diets, which have garnered attention for their anti-tumor and anti-inflammatory characteristics among various dietary treatments. This review examines the effect of a ketogenic diet in combination with chemotherapy or immunotherapy on cancer patient survival rates.